Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1–MDM2–p53 Pathway
Author:
Publisher
Elsevier
Reference147 articles.
1. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors;Brenner;Cancer Causes Control,2016
2. New therapeutic strategies for triple-negative breast cancer;Szekely;Oncology,2017
3. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2017
4. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat Rev Clin Oncol,2016
5. Systemic therapy of advanced/metastatic breast cancer—current evidence and future concepts;Liedtke;Breast Care,2016
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop;Cancer Letters;2024-02
2. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC;Open Medicine;2023-01-01
3. Companion-Probe & Race platform for interrogating nuclear protein and migration of living cells;Biosensors and Bioelectronics;2022-08
4. Japonicone A and related dimeric sesquiterpene lactones: molecular targets and mechanisms of anticancer activity;Inflammation Research;2022-01-16
5. Identification and evolution of transcription factors RHR gene family (NFAT and RBPJ) involving lamprey (Lethenteron reissneri) innate immunity;Molecular Immunology;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3